https://www.selleckchem.com/pr....oducts/mivebresib-ab
ms may support self-management and shared decision-making in spasticity management.Most of the biomedical materials printed using 3D bioprinting are static and are unable to alter/transform with dynamic changes in the internal environment of the body. The emergence of four-dimensional (4D) printing addresses this problem. By preprogramming dynamic polymer materials and their nanocomposites, 4D printing is able to produce the desired shapes or transform functions under specific conditions or stimuli to better adapt to the sur
Like
Comment
Share